Physician profile
Michael Phillip Schaefer
NPI 1033132683
$888.43
in general payments reported to CMS, 2019-2025
8 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.50 · 2020: $319 · 2021: $18.10 · 2023: $127 · 2024: $40.10 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $221.89 | 2019-2024 | Sprint Pns System |
| Mml US, INC. | $181.06 | 2025 | Reactiv8 |
| Mindray Ds USA, INC. | $134.00 | 2020 | |
| Si-Bone, INC. | $126.81 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $106.34 | 2025 | Dysport |
| Pfizer INC. | $57.29 | 2019 | |
| Organogenesis INC. | $43.93 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $17.11 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.